Joint with: Cancer Epigenetics: New Mechanisms and Therapeutic Opportunities
Gene Regulation: From Mechanisms to Disease

Jan 26–30, 2020 | Keystone Resort, Keystone, CO, United States
Scientific Organizers: Karen Adelman and Patrick Cramer

  In Person

Jan 26–30, 2020 | Keystone Resort, Keystone, CO, United States
Scientific Organizers: Karen Adelman and Patrick Cramer

Supported by the  Directors' Fund
Important Deadlines
Early Registration Deadline: November 26, 2019
Scholarship Deadline: October 1, 2019
Short Talk Abstract Deadline: Deadlines not yet available for this meeting.
Poster Abstract Deadline: October 1, 2019
Meeting Summary

# Biochemistry, Structural and Cellular
# Genetics, Genomics and RNA
Organismal development, homeostasis and healthy aging all rely on precise control of gene expression programs. Recent technological advances in structural biology, real-time imaging, and next generation sequencing have shed new light on decades-old questions about gene regulation, and we seek to highlight these advances. This meeting aims to bring together pioneers in cryoEM, single-cell microscopy, single cell sequencing and three-dimensional genome architecture, with leading experts in transcriptional regulation, to seed new collaborations and discoveries. This conference provides an ideal environment to foster interactions between transcriptional biologists and experts in single cell imaging and genomic approaches and spur conversations about how to interweave new techniques for structural biology with our growing appreciation that many critical interactions involve intrinsically disordered domains (which are by definition not well behaved in most structural approaches). Participants will attend sessions that critically evaluate the impact of genome organization on gene expression. The conference will also expose trainees to the best science possible and instill in them the enthusiasm we feel for the future of the field. Finally, pairing of this meeting with Cancer Epigenetics is ideal as the topics are inherently related. This allows our meeting to focus on underlying mechanisms and normal developmental systems, while enabling the audience to attend lectures in gene dysregulation in cancer. We plan two joint sessions to maximize interactions.
KEYSTONE SYMPOSIA THANKS OUR GIFT-IN-KIND MEDIA SPONSORS

Subscribe for Updates